A Randomized, Double-blind, Placebo-controlled, Parallel-group, Pilot Study of Cannabidiol-rich Botanical Extract in the Symptomatic Treatment of Ulcerative Colitis

Vedolizumab: an α4β7 integrin antagonist for ulcerative colitis and Crohn’s disease

(2015) Lauren N. Cherry et al.   Therapeutic Advances in Chronic Disease

A review of the cultivation and processing of cannabis (Cannabis sativaL.) for production of prescription medicines in the UK

(2013) David J. Potter   Drug Testing and Analysis

Cannabis use amongst patients with inflammatory bowel disease

(2011) Simon Lal et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

The effects of Δ9-tetrahydrocannabinol and cannabidiol alone and in combination on damage, inflammation andin vitromotility disturbances in rat colitis

(2010) JM Jamontt et al.   BRITISH JOURNAL OF PHARMACOLOGY

Cannabidiol, a safe and non-psychotropic ingredient of the marijuana plant Cannabis sativa, is protective in a murine model of colitis

(2009) Francesca Borrelli et al.   JOURNAL OF MOLECULAR MEDICINE-JMM

Ulcerative Colitis Induces Changes on the Expression of the Endocannabinoid System in the Human Colonic Tissue

(2009) Lucia Marquéz et al.   PLoS One

Cannabidiol, extracted fromCannabis sativa, selectively inhibits inflammatory hypermotility in mice

(2008) R Capasso et al.   BRITISH JOURNAL OF PHARMACOLOGY

Use of the noninvasive components of the mayo score to assess clinical response in Ulcerative Colitis

(2008) James D. Lewis et al.   INFLAMMATORY BOWEL DISEASES

Therapeutic strategies for the management of ulcerative colitis

(2008) Siew C. Ng et al.   INFLAMMATORY BOWEL DISEASES

Cannabinoid CB2receptors in the gastrointestinal tract: a regulatory system in states of inflammation

(2007) K L Wright et al.   BRITISH JOURNAL OF PHARMACOLOGY